Protein–protein interactions (PPIs) govern all biological processes. Some small molecules modulate PPIs through induced protein proximity. In particular, molecular glue degraders are monovalent compounds that orchestrate interactions between a target protein and an E3 ubiquitin ligase, prompting the proteasomal degradation of the former. This and other pharmacological strategies of targeted protein degradation (e.g. proteolysis-targeting chimeras – PROTACs) overcome some limitations of traditional occupancy-based therapeutics. Here, we provide an overview of the “molecular glue” concept, with a special focus on natural and synthetic inducers of proximity to E3s. We then briefly highlight the serendipitous discoveries of some clinical and preclinical molecular glue degraders, and discuss the first examples of intentional discoveries. Specifically, we outline the different screening strategies reported in this rapidly evolving arena and our thoughts on future perspectives. By mastering the ability to influence PPIs, molecular glue degraders can induce the degradation of unligandable proteins, thus providing an exciting path forward to broaden the targetable proteome.
Computer simulation techniques are gaining a central role in molecular pharmacology. Due to several factors, including the significant improvements of traditional molecular modelling, the irruption of machine learning methods, the massive data generation, or the unlimited computational resources through cloud computing, the future of pharmacology seems to go hand in hand with in silico predictions. In this review, we summarize our recent efforts in such a direction, centered on the unconventional Monte Carlo PELE software and on its coupling with machine learning techniques. We also provide new data on combining two recent new techniques, aquaPELE capable of exhaustive water sampling and fragPELE, for fragment growing.
ClC-5 is a Cl−/H+ antiporter crucial for the homeostasis of the entire organism, and whose functional deficiencies cause pathologies such as Dent's disease, a rare genetic disorder that can have lethal consequences. While the clinical aspects of the pathology are known, its molecular basis is elusive, which hampers the development of potential therapies. We present here a systematic study, where we explore the mechanism of transport of ClC-5, deciphering the choreography of structural changes required for the transport of chloride ions and protons in opposing directions. Once the mechanism is determined, we explore how the 523ΔVal deletion linked to Dent's disease hampers the correct functioning of the transporter, despite having a very minor structural impact. Our study highlights how state-of-the-art simulation methods can shed light on the origin of rare diseases and explore targets for personalized medicine.
PROTACs (Proteolysis-Targeting Chimeras) have emerged as a powerful modality for targeted protein degradation, yet their optimization still relies heavily on trial-and-error methods. A key factor in PROTAC degradation efficiency is the formation of the ternary complex (TC) between the PROTAC and its target proteins. However, due to their dynamic nature, PROTAC-mediated TCs can adopt multiple conformations, making their characterization challenging. Computational methods that account for this flexibility can provide more accurate predictions aligned with experimental results. Here, we explore the dynamic nature of TCs by analyzing their energy landscapes using protein-protein docking coupled with Monte Carlo sampling. This approach enables the identification of energetically relevant TC conformations, including those observed in experimental crystal structures, and allows estimation of thermodynamic and kinetic stability, as shown for a set of VHL-WDR5 PROTACs. Insights from these landscapes could support the screening and optimization of tens of similar PROTACs based on TC stability.